Pharma & Biotech

The investment narrative surrounding BioNTech is currently being shaped by a confluence of challenges. Despite the company's strategic moves to...

ImmunityBio is making a prominent appearance at the 38th Annual ROTH Conference this week, a move underscored by a remarkable...

The competitive landscape for Germany's online pharmacy market is intensifying. Rossmann has announced its intention to launch an online pharmacy...

Novo Nordisk convenes its annual general meeting this Thursday against a backdrop of significant challenges. Two pivotal events define the...

Redcare Pharmacy is poised for a significant leadership transition at the highest level of its supervisory board. The upcoming Annual...

Valneva's recently published 2025 annual results reveal a company at a strategic crossroads. While its core business demonstrates resilience, the...

Investors in Bluechiip Limited have now received definitive confirmation of a total loss. The company's journey, which began with the...

The year 2026 is shaping up to be a decisive period for BioNTech as it seeks to solidify its transition...

ImmunityBio is advancing the commercial potential of its flagship therapy, ANKTIVA, with a new regulatory submission to the U.S. Food...

While Siemens Healthineers has achieved a significant diagnostic breakthrough with its new blood-based Alzheimer's tests, investor focus remains firmly fixed...